Home
Buy & Subscribe
Special Features
Products & Services
Online Store
Products by category
Products by publisher
Product lines
News Channels
Biotechnology
Therapeutic Areas
Business
RSS Feeds
Free RSS News
Get the latest news direct
to your desktop
feed image

Search in our News Channels

 

Search in our Online Store

This Week in R&D Pipeline News

Read the highlights of the most recent edition of our weekly R&D information product R&D Pipeline News. The Special Product or Technology Pipelines of R&D Pipeline News are available via subscription of R&D Pipeline News or as a single Competitor Analysis.

Volume 4, Issue 32: PDGF /-R Biologics

 

Target Pipeline:

  • PDGF /-R Biologics

Company Pipelines:

  • PDGF /-R Biologics

More Details inside R&D Pipeline News
Get your annual subscription and receive this issue for free!

R&D Pipeline News

Get your Subscription Now

R&D Pipeline News is a premier information source about research and development (R&D) projects in the pipeline of the biopharmaceutical industry and is directed to all stakeholders in R&D . R&D Pipeline News covers all relevant treatment modalities, including. drugs, medical devices, biomaterials, combination products, cell therapy and drug delivery products.

  • The Technology Edition lists the News in groups according to the product category, e.g. antibodies or vaccines etc. The product is delivered every week as a PDF directly to your desktop via e-mail.
  • The Therapeutic Area Edition lists the News in groups according to the Therapautic Area, e.g. oncology, neurology, etc
  • Or Get a 3-weeks free trial

 

   Order     Display # 
Date Item Title Hits
23 Oct 2006 R&D Pipeline News Vol. 2, Issue 41: MEK Inhibitors 818
16 Oct 2006 R&D Pipeline News Vol. 2, Issue 40: B-Raf kinase inhibitors 822
09 Oct 2006 R&D Pipeline News Vol. 2, Issue 39: Lewis Y 748
02 Oct 2006 R&D Pipeline News Vol. 2, Issue 38: EpCAM 823
26 Sep 2006 R&D Pipeline News Vol. 2, Issue 37: alpha-1 Proteinase Inhibitors 729
18 Sep 2006 R&D Pipeline News Vol. 2, Issue 36: EGF-R (Biologics) 835
08 Sep 2006 R&D Pipeline News Vol. 2, Issue 35: ALS and Company Pipelines 808
04 Sep 2006 R&D Pipeline News Vol. 2, Issue 34: Psoriasis 681
14 Aug 2006 R&D Pipeline News Vol. 2, Issue 31: mTOR Inhibitors 729
07 Aug 2006 R&D Pipeline News Vol. 2, Issue 30: VEGF Agonists, Poly (ADP-ribose) polymerase (PARP) Inhibitors and more 690
31 Jul 2006 R&D Pipeline News Vol. 2, Issue 29: SIP-R, IL-23/R, IL-13/R, GM-CSF/receptor, CD19 and more 664
03 Jul 2006 R&D Pipeline News Vol. 2, Issue 25: Updated Competitor Analysis G-CSF and GM-CSF 879
26 Jun 2006 R&D Pipeline News Vol. 2, Issue 24: Johnson & Johnson: full development pipeline 1032
19 Jun 2006 R&D Pipeline News Vol. 2, Issue 23: Update on Thrombopoiesis Stimulating Agents 765
12 Jun 2006 R&D Pipeline News Vol. 2, Issue 22: News from ASCO 2006 771
02 Jun 2006 R&D Pipeline News Vol. 2, Issue 21: Update on Erythropoiesis-Stimulating Agents (ESA) 858
29 May 2006 R&D Pipeline News Vol. 2, Issue 20: Wyeth, Dong-A & ViroMed Pipelines 794
22 May 2006 R&D Pipeline News Vol. 2, Issue 19: PDE-4 Inhibitors 841
15 May 2006 R&D Pipeline News Vol. 2, Issue 18: Interferons 749
08 May 2006 R&D Pipeline News Vol. 2, Issue 17: Syk kinase Inhibitors 828
02 May 2006 R&D Pipeline News Vol. 2, Issue 16: Pipeline of adult allogeneic mesenchymal stem cells 684
25 Apr 2006 R&D Pipeline News Vol. 2, Issue 15: Small interfering RNA (siRNA or RNAi) 701
11 Apr 2006 R&D Pipeline News Vol. 2, Issue 14: Antibodies in Rheumatoid Arthritis 797
04 Apr 2006 R&D Pipeline News Vol. 2, Issue 13: Biologicals as VEGF and VEGF-R antagonists 778
28 Mar 2006 R&D Pipeline News Vol. 2, Issue 12: Inclu. Company profile Bayer Schering Pharma 825
21 Mar 2006 R&D Pipeline News Vol. 2, Issue 11: inclu. Anti-CD20 Antibody Pipeline 828
14 Mar 2006 R&D Pipeline News Vol. 2, Issue 10: inclu. Insulin Competitor Analysis 833
07 Mar 2006 R&D Pipeline News Vol. 2, Issue 09: inclu. IGF-1R antagonists 824
28 Feb 2006 R&D Pipeline News Vol. 2, Issue 08: inclu. Special Antibody Pipelines 960
21 Feb 2006 R&D Pipeline News Vol. 2, Issue 07: inclu. Cannabinoid-1 (CB1) receptor antagonists 1029
 
<< Start < Prev 1 2 3 4 5 Next > End >>
Results 91 - 120 of 122

PipelineReview.com is powered by La Merie Business Intelligence La Merie Business Intelligence

For immediate assistance, please call us during business hours: Mon-Fri 09:00am - 18:30pm; GMT+01

La Merie S.L | Passatge Jordi Ferran, 20 | E-08028 Barcelona | T +34 93 342 91 97 | F +34 93 342 91 98 | Email info@lamerie.com | Internet www.lamerie.com
All contents © by La Merie S. L

Competitor Analysis Series

Thrombopoiesis-Stimulating Agents (TPO)

Order Now

Brief Report Series

CD40 and CD40L (CD154) Agonists & Antagonists

Order Now

Subscribe La Merie Biologics